Secukinumab proves successful against psoriatic arthritis in FUTURE 2 trialJuly 17, 2015Psoriatic ArthritisSpondyloarthropathies
WCD: Touch avoidance is a new dimension of psoriatic impairmentJuly 13, 2015Psoriatic ArthritisSpondyloarthropathies
FDA will strengthen heart attack, stroke risk warnings for all NSAIDsJuly 9, 2015PainOsteoarthritisRheumatoid ArthritisSpondyloarthropathiesBusiness of Medicine
EULAR’s psoriatic arthritis recommendations gain new drugsJuly 1, 2015Psoriatic ArthritisSpondyloarthropathies
EULAR: Panel targets six rheumatic disease comorbiditiesJuly 1, 2015Rheumatoid ArthritisPsoriatic ArthritisGoutLupus & Connective Tissue DiseasesSpondyloarthropathies
WCD: Secukinumab shows effectiveness for nail, palmoplantar psoriasisJune 28, 2015SpondyloarthropathiesPsoriatic Arthritis
WCD: IL-23p19 inhibitors yield ‘promising’ psoriasis resultsJune 28, 2015Psoriatic ArthritisSpondyloarthropathies
WCD: Ixekizumab beats etanercept for psoriatic itchJune 27, 2015SpondyloarthropathiesPsoriatic Arthritis
VIDEO: Could a deep Koebner phenomenon trigger psoriatic arthritis?June 27, 2015Psoriatic ArthritisSpondyloarthropathies
Counseling key to guiding rheumatic disease treatment during pregnancyJune 25, 2015Rheumatoid ArthritisAnkylosing spondylitisSpondyloarthropathiesLupus & Connective Tissue Diseases
Amgen’s termination of brodalumab stuns psoriasis worldJune 25, 2015Psoriatic ArthritisSpondyloarthropathies
Lasting ustekinumab benefits seen in psoriatic arthritisJune 22, 2015Psoriatic ArthritisSpondyloarthropathies
EULAR: Panel previews updated CVD recommendationsJune 19, 2015Rheumatoid ArthritisSpondyloarthropathies
Large-scale psoriasis study links trauma to arthritisJune 16, 2015Psoriatic ArthritisSpondyloarthropathies
